Impressive Revenue Growth
ATEC reported total revenue of $151 million for Q3, representing a 27% increase year-over-year and a 4% sequential rise.
Surgical Revenue Surge
Surgical revenue reached $135 million, a 30% year-over-year growth, driven by a 20% increase in procedural volume and 9% growth in average revenue per procedure.
Record EOS Orders
Year-to-date EOS order volume has been the strongest ever, indicating positive momentum for Q4 and 2025.
Profitability Improvements
Adjusted EBITDA for Q3 was $7.4 million, marking the second consecutive quarter of positive adjusted EBITDA and a significant improvement from a loss of $400,000 in the prior year.
Cash Generation on Track
ATEC reduced cash burn by over 50% sequentially in Q3 and expects to generate positive cash flow in Q4 2024.
Strong Sales Force Expansion
Record EOS orders and new surgeon growth of 19% indicate expansion and acceptance of ATEC’s offerings.
Increased Financial Guidance
ATEC raised its full-year revenue growth guidance to 25%, expecting approximately $605 million in total revenue.